Biesbrock Aaron R, Bartizek Robert D, Gerlach Robert W, Jacobs Stephen A, Archila Luis
Health Care Research Center, The Procter & Gamble Company, 8700 Mason-Montgomery Rd., Cincinnati, Ohio 45040-9462, USA.
Am J Dent. 2003 Apr;16(2):99-104.
To assess whether the anti-caries effectiveness of three concentrations of fluoride dentifrice (placebo, 500 ppm F- and 1450 ppm F-) could be differentiated with small sample sizes in short time frames.
A controlled fluoride (F) dose-response study was conducted in concurrence with a supervised school oral hygiene regimen to assess whether dentifrices with increasing fluoride levels could be differentiated with small sample sizes in short time frames. The study was a randomized, double-blind study conducted for a period of 21 months. Subjects (N = 657 with approximately 219 per group) were randomized to placebo dentifrice, 500 ppm F- dentifrice or 1450 ppm F- dentifrice treatments for the first 9 months of the study. Subjects in the placebo group were then switched to either 500 ppm F- or 1450 ppm F- dentifrice for the remainder of the study, while subjects in the fluoride groups continued with their original treatment assignments. A calibrated examiner measured visual-tactile caries as DMFS that was supplemented with a radiographic examination at baseline, 9 months and 21 months for each subject.
The mean caries increments at 9 months were 0.35 surfaces, 0.34 surfaces, and 1.28 surfaces for the 1450 ppm F-, 500 ppm F-, and placebo groups, respectively. The mean caries increments at 21 months were 0.21 surfaces, 0.26 surfaces, 1.75 surfaces and 1.90 surfaces for the 1450 ppm F-, 500 ppm F-, placebo/1450 ppm F-, and placebo/500 ppm F- groups, respectively. The 500 ppm F- and 1450 ppm F- fluoride dentifrices delivered statistically significantly (P< 0.05) lower DMFS scores than the placebo control dentifrice at 9 months, while at 21 months the 500 ppm F- and 1450 ppm F- fluoride dentifrices delivered statistically significantly lower DMFS scores as compared to the both the placebo/500 ppm F- and the placebo/1450 ppm F- dentifrice groups. There was no evidence of a dose response (1450 ppm F- < 500 ppm F-) at 9 months or at 21 months. In this study, the effectiveness of the two fluoride dentifrices was observed at 9 months and these outcomes were still present at 21 months, confirming that caries benefits can be observed in time frames as short as 9 months with approximately 200 subjects per treatment group.
评估三种浓度的含氟牙膏(安慰剂、500 ppm F⁻和1450 ppm F⁻)在短时间内使用小样本量时能否区分其防龋效果。
在一项有监督的学校口腔卫生方案的同时进行了一项对照氟剂量反应研究,以评估含氟量增加的牙膏在短时间内使用小样本量时能否区分。该研究是一项为期21个月的随机双盲研究。受试者(N = 657,每组约219人)在研究的前9个月被随机分为安慰剂牙膏组、500 ppm F⁻牙膏组或1450 ppm F⁻牙膏组。安慰剂组的受试者在研究的剩余时间内改为使用500 ppm F⁻或1450 ppm F⁻牙膏,而氟化物组的受试者继续使用其原来分配的治疗牙膏。一名经过校准的检查者通过视触觉检查龋齿情况,记录为DMFS,并在基线、9个月和21个月时对每个受试者进行补充的X线检查。
在9个月时,1450 ppm F⁻组、500 ppm F⁻组和安慰剂组的平均龋齿增加量分别为0.35个牙面、0.34个牙面和1.28个牙面。在21个月时,1450 ppm F⁻组、500 ppm F⁻组、安慰剂/1450 ppm F⁻组和安慰剂/500 ppm F⁻组的平均龋齿增加量分别为0.21个牙面、0.26个牙面、1.75个牙面和1.90个牙面。在9个月时,500 ppm F⁻和1450 ppm F⁻含氟牙膏的DMFS得分在统计学上显著低于安慰剂对照牙膏(P < 0.05),而在21个月时,500 ppm F⁻和1450 ppm F⁻含氟牙膏的DMFS得分与安慰剂/500 ppm F⁻组和安慰剂/1450 ppm F⁻组相比在统计学上显著更低。在9个月或21个月时均没有剂量反应(1450 ppm F⁻ < 500 ppm F⁻)的证据。在本研究中,两种含氟牙膏的效果在9个月时即可观察到,并且这些结果在21个月时仍然存在,证实了在每个治疗组约200名受试者的情况下,在短短9个月的时间内即可观察到防龋益处。